{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:50:34Z","timestamp":1773240634892,"version":"3.50.1"},"reference-count":39,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2014,8,26]]},"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>We aimed to evaluate the prognostic value of routine use of PCR amplification of immunoglobulin gene rearrangements in bone marrow (BM) staging in patients with follicular lymphoma (FL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Clonal rearrangements were assessed by immunoglobulin heavy and light-chain gene rearrangement analysis in BM aspirates from 96 patients diagnosed with FL and related to morphological detection of BM involvement in biopsies. In 71 patients, results were also compared with concurrent flow cytometry analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>BM involvement was detected by PCR in 34.4% (33\/96) of patients. The presence of clonal rearrangements by PCR was associated with advanced clinical stage (I\u2013III vs IV; p&lt;0.001), high FL International Prognostic Index (FLIPI) score (0\u20131, 2 vs \u22653; p=0.003), and detection of BM involvement by morphology and flow cytometry analysis (p&lt;0.001 for both). PCR-positive patients had a significantly poorer survival than PCR-negative patients (p=0.001, log-rank test). Thirteen patients positive by PCR but without morphologically detectable BM involvement, had significantly poorer survival than patients with negative morphology and negative PCR result (p=0.002). The poor survival associated with BM involvement by PCR was independent of the FLIPI score (p=0.007, Cox regression). BM involvement by morphology or flow cytometry did not show a significant impact on survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results showed that routine use of PCR-based clonality analysis significantly improved the prognostic impact of BM staging in patients with FL. BM involvement by PCR was also an independent adverse prognostic factor.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2014-202382","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T23:19:58Z","timestamp":1411082398000},"page":"1072-1077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma"],"prefix":"10.1136","volume":"67","author":[{"given":"Ellen","family":"Berget","sequence":"first","affiliation":[{"name":"The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pathology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Helgeland","sequence":"additional","affiliation":[{"name":"The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pathology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Liseth","sequence":"additional","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turid","family":"L\u00f8keland","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Molven","sequence":"additional","affiliation":[{"name":"The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pathology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav Karsten","family":"Vintermyr","sequence":"additional","affiliation":[{"name":"The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Pathology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"2025092505110968000_67.12.1072.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"2025092505110968000_67.12.1072.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"2025092505110968000_67.12.1072.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257"},{"key":"2025092505110968000_67.12.1072.4","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701882187"},{"key":"2025092505110968000_67.12.1072.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3991"},{"key":"2025092505110968000_67.12.1072.6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23313"},{"key":"2025092505110968000_67.12.1072.7","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"2025092505110968000_67.12.1072.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05046.x"},{"key":"2025092505110968000_67.12.1072.9","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.52.4.294"},{"key":"2025092505110968000_67.12.1072.10","doi-asserted-by":"publisher","DOI":"10.1309\/EG2M-YHB9-WEFW-7H1R"},{"key":"2025092505110968000_67.12.1072.11","doi-asserted-by":"publisher","DOI":"10.1159\/000101712"},{"key":"2025092505110968000_67.12.1072.12","doi-asserted-by":"publisher","DOI":"10.1159\/000095826"},{"key":"2025092505110968000_67.12.1072.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.04.014"},{"key":"2025092505110968000_67.12.1072.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"2025092505110968000_67.12.1072.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404467"},{"key":"2025092505110968000_67.12.1072.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404479"},{"key":"2025092505110968000_67.12.1072.17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.061622"},{"key":"2025092505110968000_67.12.1072.18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1756-8722-2-49","article-title":"Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI)","volume":"22","author":"Talaulikar","year":"2009","journal-title":"J Hematol Oncol"},{"key":"2025092505110968000_67.12.1072.19","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.788697"},{"key":"2025092505110968000_67.12.1072.20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10584"},{"key":"2025092505110968000_67.12.1072.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403376"},{"key":"2025092505110968000_67.12.1072.22","unstructured":"Swerdlow SH Campo E Harris NL . eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: IARC Press, 2008."},{"key":"2025092505110968000_67.12.1072.23","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.081109"},{"key":"2025092505110968000_67.12.1072.24","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199709000-00009"},{"key":"2025092505110968000_67.12.1072.25","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-199804000-00005"},{"key":"2025092505110968000_67.12.1072.26","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-199906000-00004"},{"key":"2025092505110968000_67.12.1072.27","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.52.7.521"},{"key":"2025092505110968000_67.12.1072.28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<55::AID-PATH501>3.0.CO;2-1"},{"key":"2025092505110968000_67.12.1072.29","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.11.835"},{"key":"2025092505110968000_67.12.1072.30","doi-asserted-by":"publisher","DOI":"10.1309\/NPQXQV82Q0R8VBKT"},{"key":"2025092505110968000_67.12.1072.31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1991.9.5.762","article-title":"Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model","volume":"9","author":"Romaguera","year":"1991","journal-title":"J Clin Oncol"},{"key":"2025092505110968000_67.12.1072.32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"J Clin Oncol"},{"key":"2025092505110968000_67.12.1072.33","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.45.9.745"},{"key":"2025092505110968000_67.12.1072.34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<894::AID-CNCR21>3.0.CO;2-O"},{"key":"2025092505110968000_67.12.1072.35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cyto.b.10023","article-title":"Flow cytometry in the bone marrow staging of mature B-cell neoplasms","volume":"54B","author":"Stacchini","year":"2003","journal-title":"Cytom Part B-Clin Cytom"},{"key":"2025092505110968000_67.12.1072.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01937.x"},{"key":"2025092505110968000_67.12.1072.37","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600709127"},{"key":"2025092505110968000_67.12.1072.38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5858\/2007-131-282-FLISBM","article-title":"Follicular lymphoma in staging bone marrow specimens\u2014correlation of histologic findings with the results of flow cytometry immunophenotypic analysis","volume":"131","author":"Iancu","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2025092505110968000_67.12.1072.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01503.x"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2014-202382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:11:21Z","timestamp":1758802281000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2014-202382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,11,14]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1136\/jclinpath-2014-202382"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2014-202382","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}